STOCK-BASED COMPENSATION PLAN (Details) (USD $) | 3 Months Ended | 9 Months Ended | 12 Months Ended |
Sep. 30, 2014 | Sep. 30, 2013 | Sep. 30, 2014 | Sep. 30, 2013 | Dec. 31, 2012 |
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items] | ' | ' | ' | ' | ' |
Number of shares in the aggregate that may be issued under the 1997 Stock-Based Compensation Plan | 2,000,000 | ' | 2,000,000 | ' | ' |
Number of options granted | ' | ' | 0 | 0 | ' |
Fair value per share (in dollars per share) | $50.33 | ' | $50.33 | ' | ' |
Cost | $743,000 | $756,000 | $2,226,000 | $2,270,000 | ' |
Capitalized | -70,000 | -59,000 | -210,000 | -178,000 | ' |
Net expense | 673,000 | 697,000 | 2,016,000 | 2,092,000 | ' |
Unrecognized compensation cost of awards granted under the plan | 3,500,000 | ' | 3,500,000 | ' | ' |
Weighted average period over which unrecognized compensation cost is to be recognized (in years) | ' | ' | '1 year 9 months 18 days | ' | ' |
Additional disclosures [Abstract] | ' | ' | ' | ' | ' |
Weighted average fair value nonvested shares-beginning balance (in dollars per share) | ' | ' | $50.73 | ' | ' |
Weighted average fair value nonvested shares-granted during the period (in dollars per share) | ' | ' | $50.12 | ' | ' |
Weighted average fair value nonvested shares-cancelled/forfeited during the period (in dollars per share) | ' | ' | $49.85 | ' | ' |
Weighted average fair value nonvested shares-vested during the period (in dollars per share) | ' | ' | $52.19 | ' | ' |
Weighted average fair value nonvested shares-ending balance (in dollars per share) | $50.33 | ' | $50.33 | ' | ' |
Officers and Key Employees | ' | ' | ' | ' | ' |
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items] | ' | ' | ' | ' | ' |
Number of shares granted | ' | ' | 68,453 | 56,464 | ' |
The range of the actual amount of shares that ultimately vest of the original share units granted (in hundredths) | ' | ' | '0% to 150% | ' | ' |
Vesting period of shares (in years) | ' | ' | '3 years | ' | ' |
Shares outstanding (in shares) | 148,664 | ' | 148,664 | ' | ' |
Cost | 584,000 | 565,000 | 1,751,000 | 1,696,000 | ' |
Restricted stock award activity, excluding accrued dividend equivalents [Roll Forward] | ' | ' | ' | ' | ' |
Nonvested shares outstanding, beginning balance (in shares) | ' | ' | 94,192 | ' | ' |
Granted (in shares) | ' | ' | 68,453 | 56,464 | ' |
Cancelled/Forfeited (in shares) | ' | ' | -13,981 | ' | ' |
Vested (in shares) | ' | ' | 0 | ' | ' |
Nonvested shares outstanding, ending balance (in shares) | 148,664 | ' | 148,664 | ' | ' |
Additional disclosures [Abstract] | ' | ' | ' | ' | ' |
Number of shares awarded during the period | ' | ' | 0 | 66,077 | ' |
Market value of shares awarded | ' | ' | ' | ' | 3,300,000 |
Officers and Key Employees | Grant Date January 2012 - TSR | ' | ' | ' | ' | ' |
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items] | ' | ' | ' | ' | ' |
Shares outstanding (in shares) | 18,268 | ' | 18,268 | ' | ' |
Fair value per share (in dollars per share) | $51.23 | ' | $51.23 | ' | ' |
Expected volatility (in hundredths) | ' | ' | 22.50% | ' | ' |
Risk-free interest rate (in hundredths) | ' | ' | 0.43% | ' | ' |
Restricted stock award activity, excluding accrued dividend equivalents [Roll Forward] | ' | ' | ' | ' | ' |
Nonvested shares outstanding, ending balance (in shares) | 18,268 | ' | 18,268 | ' | ' |
Additional disclosures [Abstract] | ' | ' | ' | ' | ' |
Weighted average fair value nonvested shares-ending balance (in dollars per share) | $51.23 | ' | $51.23 | ' | ' |
Officers and Key Employees | Grant Date January 2012 - EPS | ' | ' | ' | ' | ' |
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items] | ' | ' | ' | ' | ' |
Shares outstanding (in shares) | 18,268 | ' | 18,268 | ' | ' |
Fair value per share (in dollars per share) | $56.93 | ' | $56.93 | ' | ' |
Restricted stock award activity, excluding accrued dividend equivalents [Roll Forward] | ' | ' | ' | ' | ' |
Nonvested shares outstanding, ending balance (in shares) | 18,268 | ' | 18,268 | ' | ' |
Additional disclosures [Abstract] | ' | ' | ' | ' | ' |
Weighted average fair value nonvested shares-ending balance (in dollars per share) | $56.93 | ' | $56.93 | ' | ' |
Officers and Key Employees | Grant Date January 2013 - TSR | ' | ' | ' | ' | ' |
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items] | ' | ' | ' | ' | ' |
Shares outstanding (in shares) | 24,797 | ' | 24,797 | ' | ' |
Fair value per share (in dollars per share) | $44.38 | ' | $44.38 | ' | ' |
Expected volatility (in hundredths) | ' | ' | 21.10% | ' | ' |
Risk-free interest rate (in hundredths) | ' | ' | 0.40% | ' | ' |
Restricted stock award activity, excluding accrued dividend equivalents [Roll Forward] | ' | ' | ' | ' | ' |
Nonvested shares outstanding, ending balance (in shares) | 24,797 | ' | 24,797 | ' | ' |
Additional disclosures [Abstract] | ' | ' | ' | ' | ' |
Weighted average fair value nonvested shares-ending balance (in dollars per share) | $44.38 | ' | $44.38 | ' | ' |
Officers and Key Employees | Grant Date January 2013 - EPS | ' | ' | ' | ' | ' |
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items] | ' | ' | ' | ' | ' |
Shares outstanding (in shares) | 24,797 | ' | 24,797 | ' | ' |
Fair value per share (in dollars per share) | $51.18 | ' | $51.18 | ' | ' |
Restricted stock award activity, excluding accrued dividend equivalents [Roll Forward] | ' | ' | ' | ' | ' |
Nonvested shares outstanding, ending balance (in shares) | 24,797 | ' | 24,797 | ' | ' |
Additional disclosures [Abstract] | ' | ' | ' | ' | ' |
Weighted average fair value nonvested shares-ending balance (in dollars per share) | $51.18 | ' | $51.18 | ' | ' |
Officers and Key Employees | Grant Date January 2014, TSR | ' | ' | ' | ' | ' |
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items] | ' | ' | ' | ' | ' |
Shares outstanding (in shares) | 31,267 | ' | 31,267 | ' | ' |
Fair value per share (in dollars per share) | $44.32 | ' | $44.32 | ' | ' |
Expected volatility (in hundredths) | ' | ' | 20.00% | ' | ' |
Risk-free interest rate (in hundredths) | ' | ' | 0.80% | ' | ' |
Restricted stock award activity, excluding accrued dividend equivalents [Roll Forward] | ' | ' | ' | ' | ' |
Nonvested shares outstanding, ending balance (in shares) | 31,267 | ' | 31,267 | ' | ' |
Additional disclosures [Abstract] | ' | ' | ' | ' | ' |
Weighted average fair value nonvested shares-ending balance (in dollars per share) | $44.32 | ' | $44.32 | ' | ' |
Officers and Key Employees | Grant Date January 2014, EPS | ' | ' | ' | ' | ' |
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items] | ' | ' | ' | ' | ' |
Shares outstanding (in shares) | 31,267 | ' | 31,267 | ' | ' |
Fair value per share (in dollars per share) | $54.44 | ' | $54.44 | ' | ' |
Restricted stock award activity, excluding accrued dividend equivalents [Roll Forward] | ' | ' | ' | ' | ' |
Nonvested shares outstanding, ending balance (in shares) | 31,267 | ' | 31,267 | ' | ' |
Additional disclosures [Abstract] | ' | ' | ' | ' | ' |
Weighted average fair value nonvested shares-ending balance (in dollars per share) | $54.44 | ' | $54.44 | ' | ' |
Directors | ' | ' | ' | ' | ' |
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items] | ' | ' | ' | ' | ' |
Number of shares granted | ' | ' | 11,610 | 12,285 | ' |
Vesting period of shares (in years) | ' | ' | '12 months | ' | ' |
Shares Vested, Directors (in hundredths) | 100.00% | ' | 100.00% | ' | ' |
Shares outstanding (in shares) | 11,610 | ' | 11,610 | ' | ' |
Cost | 159,000 | 191,000 | 475,000 | 574,000 | ' |
Restricted stock award activity, excluding accrued dividend equivalents [Roll Forward] | ' | ' | ' | ' | ' |
Nonvested shares outstanding, beginning balance (in shares) | ' | ' | 19,617 | ' | ' |
Granted (in shares) | ' | ' | 11,610 | 12,285 | ' |
Cancelled/Forfeited (in shares) | ' | ' | 0 | ' | ' |
Vested (in shares) | ' | ' | -19,617 | ' | ' |
Nonvested shares outstanding, ending balance (in shares) | 11,610 | ' | 11,610 | ' | ' |
Additional disclosures [Abstract] | ' | ' | ' | ' | ' |
Market value of shares awarded | ' | ' | $600,000 | $600,000 | ' |
Directors | Grant Date January 2014 | ' | ' | ' | ' | ' |
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items] | ' | ' | ' | ' | ' |
Shares outstanding (in shares) | 11,610 | ' | 11,610 | ' | ' |
Fair value per share (in dollars per share) | $54.51 | ' | $54.51 | ' | ' |
Restricted stock award activity, excluding accrued dividend equivalents [Roll Forward] | ' | ' | ' | ' | ' |
Nonvested shares outstanding, ending balance (in shares) | 11,610 | ' | 11,610 | ' | ' |
Additional disclosures [Abstract] | ' | ' | ' | ' | ' |
Weighted average fair value nonvested shares-ending balance (in dollars per share) | $54.51 | ' | $54.51 | ' | ' |
Minimum | Officers and Key Employees | ' | ' | ' | ' | ' |
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items] | ' | ' | ' | ' | ' |
Percentage of actual amount of shares that ultimately vest of original share units granted | ' | ' | 0.00% | ' | ' |
Maximum | Officers and Key Employees | ' | ' | ' | ' | ' |
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items] | ' | ' | ' | ' | ' |
Percentage of actual amount of shares that ultimately vest of original share units granted | ' | ' | 150.00% | ' | ' |
Stock Appreciation Rights (SARs) | ' | ' | ' | ' | ' |
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items] | ' | ' | ' | ' | ' |
Number of shares granted | ' | ' | 0 | 0 | ' |
Restricted stock award activity, excluding accrued dividend equivalents [Roll Forward] | ' | ' | ' | ' | ' |
Granted (in shares) | ' | ' | 0 | 0 | ' |